Medtronic (MDT) Accounts Payables (2014 - 2026)

Medtronic (MDT) has 13 years of Accounts Payables data on file, last reported at $2.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 7.96% year-over-year to $2.6 billion; the trailing twelve-month figure through Apr 2026 stood at $2.6 billion (up 7.96% YoY), and the FY2026 full-year result was $2.6 billion, up 7.96% from the prior year.
• Accounts Payables rose to $2.6 billion in Q2 2026, from $2.6 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.7 billion in Q2 2023 to a low of $2.0 billion in Q1 2022.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables rose 16.96% in 2023 and retreated 9.82% in 2024, its largest moves.
• Tracing MDT's Accounts Payables over 5 years: stood at $2.2 billion in 2022, then fell by 1.09% to $2.2 billion in 2023, then climbed by 9.29% to $2.4 billion in 2024, then advanced by 8.63% to $2.6 billion in 2025, then increased by 2.44% to $2.6 billion in 2026.
• Business Quant data shows MDT's Accounts Payables at $2.6 billion in Q2 2026, $2.6 billion in Q1 2026, and $2.6 billion in Q4 2025.